[go: up one dir, main page]

Kupczyk-Subotkowska et al., 1997 - Google Patents

Derivatives of melphalan designed to enhance drug accumulation in cancer cells

Kupczyk-Subotkowska et al., 1997

Document ID
8626311505201776196
Author
Kupczyk-Subotkowska L
Tamura K
Pal D
Sakaeda T
Siahaan T
Stella V
Borchardt R
Publication year
Publication venue
Journal of drug targeting

External Links

Snippet

The objective of this study was to develop chemical strategies to improve the uptake and accumulation of melphalan (L-Mel and D-Mel), a cytotoxic agent, into cancer cells. Dipeptides synthesized from L-(or D-) Mel and L-glutamic acid (L-Glu) or L-valine (L-Val) …
Continue reading at www.tandfonline.com (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C07K1/061General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton

Similar Documents

Publication Publication Date Title
Maryanoff et al. Macrocyclic peptide inhibitors of serine proteases. Convergent total synthesis of cyclotheonamides A and B via a late-stage primary amine intermediate. Study of thrombin inhibition under diverse conditions
JP3579750B2 (en) Human cancer inhibitory pentapeptide methyl esters
AU636521B2 (en) Inhibitors and substrates of thrombin
US6323315B1 (en) Dolastatin peptides
JPH0381256A (en) renin inhibitor
NZ261630A (en) Heteromacrocyclic compound and use as an assthelmintie
KR20110022594A (en) Novel Dual Targeting Antitumor Conjugates
EP0646596B1 (en) Nucleic acid binding oligomers having C-branches for therapy and diagnosis
AU731757B2 (en) Semi-synthetic studies toward didemnin analogues
Kupczyk-Subotkowska et al. Derivatives of melphalan designed to enhance drug accumulation in cancer cells
Gruzdev et al. Synthesis of closo-and nido-carborane derivatives of the KRGD peptide
AU721261B2 (en) Peptide inhibitors of hematopoietic cell proliferation
EP0641776A2 (en) Thioglycerol derivatives
ZA200300080B (en) Thrombin inhibitors comprising an aminoisoquinoline group.
Andruszkiewicz et al. Antimicrobial properties of N3-(iodoacetyl)-L-2, 3-diaminopropanoic acid-peptide conjugates
JPS63101398A (en) Oligopeptide antibiotic, its production and drug containing said antibiotic
WO2013118823A1 (en) Method for producing cereulide and derivative thereof, intermediate for production of cereulide, and cereulide derivative
EP0309971A2 (en) New spergualin-related compound and pharmaceutical composition
Ma et al. Total synthesis and stereochemical reassignment of tasiamide
HU199878B (en) Process for producing acylated splenopentynes and pharmaceutical compositions comprising such compounds as active ingredient
US5863937A (en) Pharmaceutical compositions
Juodka et al. Oligonucleotides and Nucleotide-Peptides. LIV. The Synthesis and Hydrolytic Properties of Adenylyl-(5′→ N∊)-lysylpeptides—Model Compounds of the AMP-RNA Ligase Covalent Complex
JPH06279489A (en) New okadaic acid derivative
KR790001842B1 (en) Process for producing novel polypeptides
JPH01193298A (en) Production of peptide